Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial

201690 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Haematology

Volume 3, Issue 2, pp. e72-e79

Field-Weighted Citation Impact: 7.51